cytarabine has been researched along with Melanoma in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 41 (67.21) | 18.7374 |
1990's | 10 (16.39) | 18.2507 |
2000's | 4 (6.56) | 29.6817 |
2010's | 5 (8.20) | 24.3611 |
2020's | 1 (1.64) | 2.80 |
Authors | Studies |
---|---|
Kim, SH; Rosowsky, A; Ross, J; Wick, MM | 1 |
Liu, L; Peng, S; Wang, Y; Wu, J; Yang, Y; Zhang, X; Zhao, M; Zheng, M | 1 |
Chen, M; Chen, X; Fang, F; Guo, J; Han, L; Hung, MC; Kuang, X; Li, H; Li, J; Liang, L; Liu, H; Liu, J; Ma, F; Peng, C; Su, J; Sun, L; Tao, J; Weng, L; Xie, Y; Xie, Z; Xu, X; Yang, N; Ye, Y; Zhang, J; Zhang, X; Zhang, Y; Zhao, S | 1 |
Bonneterre, J; Boulanger, T; Durand, B; Le Rhun, E; Mortier, L; Zairi, F | 1 |
Ashworth, MT; Daud, AI; Freshwater, T; Goldman, JW; Grabowsky, JA; Isaacs, R; Kang, SP; Loechner, S; Mendelson, D; Munster, PN; Parry, D; Rosen, LS; Shanahan, F; Shumway, S; Sorge, C; Springett, G; Strosberg, J; Venook, AP | 1 |
Aboukais, R; Assaker, R; Bertrand, N; Boulanger, T; Chamberlain, MC; Le Rhun, E; Taillibert, S; Zairi, F | 1 |
Aamdal, S; Dueland, S; Gaullier, JM; Lind, MJ; Rasch, W; Sandvold, ML; Thomas, H | 1 |
Andarawewa, KL; Conaway, MR; Coyner, M; Frierson, HF; Markland, F; McRoberts, K; Sanders, JM; Schwartz, MA; Swenson, S; Theodorescu, D | 1 |
Blasius, E; Glas, M; Herrlinger, U; Moehlenbruch, M; Rasch, K; Schaefer, N; Scheffler, B; Stuplich, M; Urbach, H | 1 |
Burch, JA; Darrow, TL; Grichnik, JM; Liu, J; Schulteis, RD; Seigler, HF; Shan, S; Vervaert, CE | 1 |
Imamishi, J; Tanaka, A | 1 |
Markman, M | 1 |
Araki, T; Ninomiya, K; Sekido, S | 1 |
Perez, DJ; Tattersall, MH | 1 |
Hori, K; Naganuma, K; Sakurai, Y; Tsukagoshi, S; Tsuruo, T | 1 |
Garcia, JH; Mena, H; Velandia, F | 1 |
Monaghan, P; Peckham, MJ; Selby, PJ; Sloane, J; Thomas, JM | 1 |
De Traversay, J; Jean, Y; Lemieux, P | 1 |
Beery, E; Cyjon, A; Fenig, E; Nordenberg, J; Panet, C; Sidi, Y | 1 |
Escudier, SM; Estey, EH; Kantarjian, HM | 1 |
Cree, IA; Foss, AJ; Hungerford, JL; Kurbacher, CM; Myatt, N; Neale, MH; Plowman, PN | 1 |
Chamberlain, MC; Cole, BF; Glantz, MJ; Howell, SB; Jaeckle, KA; LaFollette, S; Maria, B; Phuphanich, S; Recht, L; Schumann, GB; Swinnen, LJ | 1 |
Endo, Y; Matsuda, A; Obata, T; Sasaki, T; Tanaka, M; Uchida, H | 1 |
Frei, E; Krishan, A; Paika, KD; Pitman, SW; Smith, DC; Tattersall, HN | 1 |
Aulepp, H; Gartmann, H; Schneider, I | 1 |
Baker, LH; Izbicki, RM; Ratanatharathorn, V; Samson, MK | 1 |
Hewlett, JS; McKelvey, EM; Thigpen, T; Whitecar, J | 1 |
Furner, RL; Mellett, LB | 1 |
Brown, SG; Parsons, PG | 1 |
Edström, S; Jacobsson, S; Jeppsson, PH | 1 |
Gailani, S; Nussbaum, A | 1 |
Armstrong, DM; Aust, JB; Cruz, AB; Dowell, KE | 1 |
Curby, WA; Rosenoer, VM | 1 |
Hayakawa, T; Izumoto, S; Kubo, S; Murasawa, A; Nakagawa, H; Nakajima, S; Nakajima, Y | 1 |
Musk, P; Parsons, PG; Stowers, A | 1 |
Djuric, L; Jeremic, B; Mijatovic, L | 1 |
Arita, M; Fujii, A; Matsuda, A; Okumoto, T; Sakata, S; Sasaki, T; Ueda, T; Yamagami, K | 1 |
de Vries, EG; Mulder, NH; Schraffordt Koops, H; Sleijfer, DT; Willemse, PH | 1 |
Lönn, S; Lönn, U | 1 |
Giannone, L; Greco, FA; Hainsworth, JD | 1 |
Pályi, I | 1 |
Bajetta, E; Bonadonna, G; Bonfante, V; Verusio, C | 1 |
Ashman, CR; Davidson, RL; Kaufman, ER | 1 |
Hartmann, HR; Hengartner, H; Rubas, W; Schott, H; Schwendener, R; Supersaxo, A; Weder, HG | 1 |
Boehm, TL; Brzoska, MJ; Drahovsky, D; Werle, A | 1 |
Lichter, W; Lopez, DM; Sigel, MM | 1 |
Jacobs, EM; Johnson, FD | 1 |
Calabresi, P; Creasey, WA; Markiw, ME; Papac, RJ; Welch, AD | 1 |
Skipper, HE | 1 |
Atwell, GJ; Cain, BF | 1 |
Dominick, CA; Dykes, DJ; Griswold, DP; Kelley, CA; Roberts, BJ | 1 |
Goldin, A | 1 |
Carter, SK | 1 |
Gutterman, JU; Hersh, EM; Mavligit, GM; Reed, RC | 1 |
Frei, E; George, SL; Gottlieb, JA; Hart, JS; Ho, DH; Salem, P | 1 |
Barranco, SC; Drewinko, B; Ho, DH; Humphrey, RM; Romsdahl, MM | 1 |
Mattern, J; Volm, M; Wayss, K | 1 |
Silagi, S | 1 |
Bertalanffy, FD; Gibson, MH | 1 |
Goldenberg, DM | 1 |
Brodovsky, HS; Burke, PJ; Colsky, J; Edmonson, JH; Hall, TC; Owens, AH; Schilling, A; Shnider, BI; Wallace, HJ | 1 |
4 review(s) available for cytarabine and Melanoma
Article | Year |
---|---|
Bromodeoxyuridine mutagenesis and deoxyribonucleotide pool imbalance in mammalian cells.
Topics: Animals; Base Composition; Bromodeoxyuridine; Cell Line; Cricetinae; Cytarabine; Deoxyadenosines; Deoxycytidine; Deoxyguanosine; Deoxyribonucleotides; DNA; Drug Resistance; Fluorouracil; Hydroxyurea; Melanoma; Mutation; Ribonucleotide Reductases; Sister Chromatid Exchange; Thymidine | 1985 |
Rationale of combination chemotherapy based on preclinical experiments.
Topics: Animals; Antineoplastic Agents; Azaguanine; Carcinoma; Cytarabine; Drug Synergism; Humans; Hydroxyurea; Immunotherapy; Leukemia L1210; Lung Neoplasms; Melanoma; Neoplasms; Thiosemicarbazones; Time Factors | 1973 |
An overview of the status of the nitrosoureas in other tumors.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Hodgkin Disease; Humans; Hydroxyurea; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Melanoma; Melphalan; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Vincristine | 1973 |
Immunochemotherapy of human cancer.
Topics: Acute Disease; Adjuvants, Immunologic; Adult; Animals; Antineoplastic Agents; BCG Vaccine; Cytarabine; Humans; Immunosuppressive Agents; Immunotherapy; Leukemia L1210; Lymphoma; Melanoma; Mice; Neoplasms; Neoplasms, Experimental; Prednisone; Vincristine | 1974 |
8 trial(s) available for cytarabine and Melanoma
Article | Year |
---|---|
Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Checkpoint Kinase 1; Cohort Studies; Cytarabine; Deoxycytidine; Female; Gemcitabine; Histones; Humans; Infusions, Intravenous; K562 Cells; Male; Melanoma; Middle Aged; Neoplasms; Protein Kinase Inhibitors; Protein Kinases; Pyrazoles; Pyrimidines; Sarcoma; Time Factors | 2015 |
Intravenous administration of CP-4055 (ELACYT) in patients with solid tumours. A Phase I study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Melanoma; Middle Aged; Neoplasms; Ovarian Neoplasms | 2009 |
Newer techniques in cancer chemotherapy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bleomycin; Bone Marrow Transplantation; Carcinoma; Cells, Cultured; Child; Cisplatin; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Cytarabine; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Hepatic Artery; Humans; Hyperthermia, Induced; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Mechlorethamine; Melanoma; Meningeal Neoplasms; Methotrexate; Neoplasms; Osteosarcoma; Peritoneal Cavity; Pleura | 1984 |
Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
Topics: Adult; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Cohort Studies; Cytarabine; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Germinoma; Hemorrhage; Humans; Idarubicin; Incidence; Infarction; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Melanoma; Middle Aged; Myocardial Infarction; Neoplasms, Multiple Primary; Remission Induction; Retrospective Studies; Spleen; Thrombosis; Treatment Outcome; Tretinoin | 1996 |
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cytarabine; Delayed-Action Preparations; Disease Progression; Female; Humans; Injections, Spinal; Lung Neoplasms; Male; Melanoma; Meningeal Neoplasms; Methotrexate; Middle Aged; Neoplasms; Prospective Studies; Survival Rate; Survivors | 1999 |
Cyclocytidine chemotherapy for malignant melanoma.
Topics: Ancitabine; Clinical Trials as Topic; Cytarabine; Humans; Melanoma; Neoplasm Metastasis | 1978 |
Carboplatinum and cytosine arabinoside in patients with disseminated malignant melanoma. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Drug Evaluation; Female; Gastrointestinal Diseases; Hematocrit; Humans; Male; Melanoma; Middle Aged; Platelet Count | 1991 |
Combination intraventricular chemotherapy for meningeal neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Lung Neoplasms; Lymphoma; Melanoma; Meningeal Neoplasms; Methotrexate; Thiotepa; Urinary Bladder Neoplasms | 1986 |
49 other study(ies) available for cytarabine and Melanoma
Article | Year |
---|---|
Lipophilic 5'-(alkyl phosphate) esters of 1-beta-D-arabinofuranosylcytosine and its N4-acyl and 2,2'-anhydro-3'-O-acyl derivatives as potential prodrugs.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Cytarabine; Drug Resistance; Esters; Hydrolysis; Leukemia L1210; Melanoma; Mice; Neoplasms, Experimental | 1982 |
A class of Trp-Trp-AA-OBzl: Synthesis, in vitro anti-proliferation/in vivo anti-tumor evaluation, intercalation-mechanism investigation and 3D QSAR analysis.
Topics: Amino Acids; Animals; Antineoplastic Agents; Body Weight; Carbolines; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cytarabine; Differential Thermal Analysis; DNA; Drug Screening Assays, Antitumor; Esters; Humans; Inhibitory Concentration 50; Intercalating Agents; Leukemia, Myeloid; Liver Neoplasms; Male; Melanoma; Mice; Mice, Inbred ICR; Models, Molecular; Neoplasm Transplantation; Organ Size; Quantitative Structure-Activity Relationship | 2011 |
ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis.
Topics: Activating Transcription Factor 3; Adenosine A1 Receptor Antagonists; Adult; Aged; Animals; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytarabine; Female; Humans; Lomustine; Lung Neoplasms; Male; Melanoma; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Mitoxantrone; Prednisone; Receptor, Adenosine A1; Tumor Escape; Xenograft Model Antitumor Assays | 2020 |
Chemical meningitis related to intra-CSF liposomal cytarabine.
Topics: Antimetabolites, Antineoplastic; Cytarabine; Humans; Injections, Spinal; Male; Melanoma; Melanoma, Cutaneous Malignant; Meningeal Carcinomatosis; Meningitis; Middle Aged; Skin Neoplasms | 2017 |
Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brain; Breast Neoplasms; Catheters, Indwelling; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Lung Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Meningeal Neoplasms; Middle Aged; Prospective Studies; Spinal Cord | 2015 |
Integrin agonists as adjuvants in chemotherapy for melanoma.
Topics: Adjuvants, Pharmaceutic; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cytarabine; Extracellular Matrix; Genes, p53; Humans; Integrins; Medical Oncology; Melanoma; Mice; Mice, SCID; Signal Transduction | 2008 |
Leptomeningeal melanomatosis: stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Dacarbazine; Humans; Injections, Spinal; Liposomes; Male; Melanoma; Meningeal Neoplasms; Middle Aged; Temozolomide | 2011 |
Melanoma, a tumor based on a mutant stem cell?
Topics: Antigens, Neoplasm; Antimetabolites, Antineoplastic; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cytarabine; Dendritic Cells; Fluorescent Dyes; gp100 Melanoma Antigen; Humans; Intermediate Filament Proteins; Melanoma; Membrane Glycoproteins; Mutation; Neoplasm Metastasis; Neoplasm Proteins; Neoplastic Stem Cells; Nerve Tissue Proteins; Nestin; Skin Neoplasms | 2006 |
[Experimental research to clinical application of interferons].
Topics: Animals; Bleomycin; Cytarabine; Drug Therapy, Combination; Humans; Interferon Inducers; Interferon Type I; Interferon-gamma; Interferons; Leukemia, Experimental; Melanoma; Mice; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Experimental | 1984 |
[Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cell Line; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Leukemia L1210; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mitomycin; Mitomycins; Nitrosourea Compounds | 1984 |
Assessment of antimetabolite cytotoxicity: a comparison of clonogenic assays and tritiated deoxyuridine incorporation.
Topics: Animals; Cell Cycle; Cell Line; Cell Survival; Clone Cells; Cytarabine; Deoxyuridine; Dose-Response Relationship, Drug; Fluorouracil; Humans; Leukemia L1210; Melanoma; Methotrexate; Mice; Tritium | 1983 |
Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
Topics: Adenocarcinoma; Administration, Oral; Animals; Colonic Neoplasms; Cytarabine; Drug Evaluation, Preclinical; Leukemia L1210; Leukemia P388; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neoplasms, Experimental | 1984 |
Central and peripheral myelinopathy associated with systemic neoplasia and chemotherapy.
Topics: Adult; Aged; Axons; Brain; Cytarabine; Cytoskeleton; Female; Humans; Injections, Spinal; Leukemia; Male; Melanoma; Middle Aged; Myelin Sheath; Skin Neoplasms; Spinal Cord; Thiotepa | 1981 |
Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation.
Topics: Animals; Cytarabine; Female; Humans; Immunosuppression Therapy; Karyotyping; Male; Melanoma; Mice; Mice, Inbred CBA; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Experimental; Ovarian Neoplasms; Radiation Effects; Thymectomy; Time Factors; Transplantation, Heterologous; Uterine Neoplasms | 1980 |
Teaching cancer chemotherapy by means of a computer simulation.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cause of Death; Computer Simulation; Computer-Assisted Instruction; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Humans; Leukemia, Experimental; Melanoma; Methotrexate; Mice; Models, Biological; Models, Educational; Neoplasms, Experimental; Sarcoma, Experimental; Software; Survival Rate; Teaching | 1994 |
Guanosine potentiates the antiproliferative effect of cytosine-beta-D-arabinofuranoside in melanoma cell lines.
Topics: Animals; Cell Cycle; Cell Division; Cytarabine; Drug Synergism; Guanosine; Humans; Melanoma; Melanoma, Experimental; Mice; Tumor Cells, Cultured | 1993 |
Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside.
Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Choroid Neoplasms; Cytarabine; Deoxycytidine; Gemcitabine; Humans; Melanoma; Paclitaxel; Tumor Stem Cell Assay | 1999 |
Deletion mutants of human deoxycytidine kinase mRNA in cells resistant to antitumor cytosine nucleosides.
Topics: Antimetabolites, Antineoplastic; Cytarabine; Deoxycytidine; Deoxycytidine Kinase; Drug Resistance, Neoplasm; Fibrosarcoma; Gene Deletion; Gene Expression; Humans; Inhibitory Concentration 50; Melanoma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2001 |
Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapy.
Topics: Antineoplastic Agents; Bone Marrow Cells; Cell Division; Cytarabine; Ethidium; Fluorometry; Humans; Leucovorin; Leukemia, Lymphoid; Melanoma; Methotrexate; Neoplasms; Staining and Labeling | 1976 |
[Histological and histochemical studies on melanoma metastases under immunobiological and cytostatic therapy].
Topics: Antineoplastic Agents; BCG Vaccine; Bleomycin; Cytarabine; Dinitrochlorobenzene; Fluorouracil; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Procarbazine; Trichophytin; Vincristine | 1976 |
Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma.
Topics: Adult; Aged; Ancitabine; Brain Neoplasms; Cytarabine; Dacarbazine; Drug Therapy, Combination; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Middle Aged; Neoplasm Metastasis; Retroperitoneal Neoplasms; Skin Neoplasms; Triazenes | 1976 |
Kinase and deaminase activity in a variety of subcutaneous mouse tumors.
Topics: Adenocarcinoma; Aminohydrolases; Animals; Cell Line; Chick Embryo; Cytarabine; Freezing; Glioma; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred AKR; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Experimental; Osteosarcoma; Phosphotransferases; Pyrimidine Nucleotides; Sarcoma 180; Tetrahydrouridine; Uridine | 1975 |
Cytotoxicity studies of human melanoma cells and fibroblasts.
Topics: Animals; Cell Survival; Cells, Cultured; Cytarabine; Dacarbazine; DNA; DNA Repair; DNA, Neoplasm; Fibroblasts; Humans; Melanoma; Melphalan | 1979 |
Mucosal melanoma. Immunological findings in a rare case treated with BCG vaccine, autologous tumor cells, and cytarabine.
Topics: Antigens, Neoplasm; BCG Vaccine; Bronchial Neoplasms; Cytarabine; Humans; Immunity, Cellular; Intestinal Mucosa; Intestinal Neoplasms; Intestine, Small; Male; Maxillary Sinus; Melanoma; Middle Aged; Mucous Membrane; Paranasal Sinus Neoplasms; Tuberculin Test | 1979 |
Correlation of response to 1-beta-D-arabinofuranosyl cytosine and metabolism of drug by tumor.
Topics: Cytarabine; Cytosine Nucleotides; Deamination; Female; Hemangiopericytoma; Humans; Leukemia; Leukemia, Myeloid; Melanoma; Middle Aged; Neoplasms; Neoplastic Cells, Circulating; Oxidative Phosphorylation; Splenic Neoplasms | 1976 |
Systemic chemotherapy of advanced head and neck malignancies.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Fluorouracil; Head; Head and Neck Neoplasms; Humans; Imidazoles; Melanoma; Methotrexate; Neoplasms; Nitrosourea Compounds; Retrospective Studies; Sarcoma; Triazenes; Vincristine | 1975 |
Growth kinetics of solid tumors. Implications for chemotherapy.
Topics: Acute Disease; Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Culture Techniques; Cytarabine; DNA; Humans; Kinetics; Leukemia; Meiosis; Melanoma; Mitosis; Neoplasms; Neoplasms, Experimental; Rats; Thymidine; Tritium; Vinblastine | 1975 |
Diagnosis and treatment of patients with meningeal carcinomatosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma; Cytarabine; Female; Humans; Injections, Spinal; Male; Melanoma; Meningeal Neoplasms; Methotrexate; Middle Aged; Retrospective Studies | 1992 |
Effects of antimetabolites on adenovirus replication in sensitive and resistant human melanoma cell lines.
Topics: Adenoviridae; Cell Survival; Cytarabine; DNA; Drug Resistance; Humans; Kinetics; Melanoma; Methotrexate; RNA; Tetrahydrofolate Dehydrogenase; Thioguanine; Tumor Cells, Cultured; Virus Replication | 1990 |
Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative.
Topics: Animals; Cytarabine; Deoxycytidine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Humans; Leukemia P388; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms; Tumor Cells, Cultured | 1991 |
Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Dacarbazine; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Organoplatinum Compounds | 1990 |
Treatment with dilute alkali-nuclease S1 permits the analysis of DNA damage: cells treated with platinum analogues.
Topics: Cell Line; Cisplatin; Cytarabine; DNA Damage; DNA Replication; DNA, Neoplasm; Endonucleases; Humans; Isomerism; Kinetics; Melanoma; Metronidazole; Organoplatinum Compounds; Single-Strand Specific DNA and RNA Endonucleases; Thiourea | 1987 |
Heterogeneity of the response to inducers of differentiation and to cytostatics of tumor cell populations.
Topics: Antineoplastic Agents; Cell Differentiation; Cisplatin; Cytarabine; Dacarbazine; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Doxorubicin; Fluorouracil; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Promyelocytic, Acute; Melanoma; Neoplasms; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Cells, Cultured | 1988 |
Cytarabine and cisplatin in advanced malignant melanoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cytarabine; Drug Evaluation; Humans; Lung Neoplasms; Melanoma | 1986 |
Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes.
Topics: Animals; Bone Marrow; Cytarabine; Female; Leukemia L1210; Liposomes; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA | 1986 |
Suppression of malignant phenotype, changes in gene expression and DNA hypermethylation in human melanoma cells treated with arabinosyl cytosine.
Topics: Cell Line; Cytarabine; DNA, Neoplasm; Humans; Kinetics; Melanoma; Methylation; Oncogenes; Phenotype; Transcription, Genetic | 1985 |
In vitro methods to complement in vivo approaches utilizing combinations of chemotherapy and immunotherapy.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Bleomycin; Carmustine; Cells, Cultured; Chickens; Clone Cells; Concanavalin A; Culture Techniques; Cytarabine; Cytological Techniques; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Immunity, Cellular; Immunotherapy; Lectins; Lipopolysaccharides; Lymphocytes; Melanoma; Mice; Mitosis; Neoplasms; Neoplasms, Experimental; Thymidine | 1974 |
Chemotherapy of metastatic malignant melanoma. Experience with 73 patients.
Topics: Adult; Aged; Antineoplastic Agents; Chlorambucil; Colchicine; Cyclophosphamide; Cytarabine; Eye Neoplasms; Female; Floxuridine; Humans; Hydroxyurea; Idoxuridine; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Nitrogen Mustard Compounds; Nitrosourea Compounds; Skin Neoplasms; Vinblastine; Vincristine; Vulvar Neoplasms | 1971 |
Biochemical and pharmacological studies with 1-beta-D-arabinofuranosylcytosine in man.
Topics: Adult; Carcinoma, Hepatocellular; Chromatography, Paper; Cytarabine; DNA; Female; Humans; Leukemia, Myeloid; Leukocytes; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma; Middle Aged; Nucleosides; RNA; RNA, Transfer; Tritium; Uracil Nucleotides; Uridine | 1966 |
Combination therapy: some concepts and results.
Topics: Animals; Antineoplastic Agents; Child; Cyclohexanes; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Imidazoles; Leukemia L1210; Lung Neoplasms; Melanoma; Mice; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds; Nitrosourea Compounds; Thioguanine; Triazenes; Wilms Tumor | 1974 |
The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series.
Topics: Acridines; Animals; Anisoles; Antineoplastic Agents; Chemical Phenomena; Chemistry, Physical; Cytarabine; Dose-Response Relationship, Drug; Injections, Intradermal; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Leukemia L1210; Leukemia, Experimental; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Phenylenediamines; Skin Neoplasms; Structure-Activity Relationship; Sulfones | 1974 |
Approaches to combination chemotherapy in rat, mouse, and hamster tumors.
Topics: Adenocarcinoma; Amides; Androstanols; Animals; Antineoplastic Agents; Cricetinae; Cyclohexanes; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Estradiol; Female; Hydroxyurea; Imidazoles; Mammary Neoplasms, Experimental; Melanoma; Melphalan; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Osteosarcoma; Plasmacytoma; Progesterone; Rats; Sarcoma, Experimental; Triazenes | 1974 |
Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma.
Topics: Adult; Aged; Aminohydrolases; Blood Cells; Bone Marrow; Bone Marrow Cells; Cytarabine; DNA; Evaluation Studies as Topic; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Phosphotransferases; Sex Factors; Skin Neoplasms; Time Factors; Tritium | 1972 |
Differential sensitivites of human melanoma cells grown in vitro to arabinosylcytosine.
Topics: Aminohydrolases; Cell Division; Cell Line; Cell Transformation, Neoplastic; Cytarabine; DNA Replication; Humans; Melanoma; Phosphotransferases | 1972 |
The effects of cytostatic drugs on transplanted tumours. An investigation of the correlation between in vivo and in vitro results.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cricetinae; Cytarabine; Daunorubicin; Fluorouracil; Melanoma; Methotrexate; Mice; Neoplasm Transplantation; Plasmacytoma; Procarbazine; Rats; Thymidine; Tritium; Uridine | 1974 |
Control of pigment production in mouse melanoma cells in vitro. Evocation and maintenance.
Topics: Animals; Antimetabolites; Autoradiography; Catechol Oxidase; Cell Differentiation; Cell Division; Cell Line; Chromosomes; Clone Cells; Colchicine; Culture Media; Cytarabine; Melanins; Melanoma; Mice; Models, Biological; Pigmentation; Time Factors; Tyrosine | 1969 |
In vivo synchrony of solid B16 melanoma by cytosine arabinoside, an inhibitor of DNA synthesis.
Topics: Animals; Autoradiography; Cell Division; Cell Survival; Cytarabine; DNA; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Melanoma; Mice; Mice, Inbred C57BL; Mitosis; Neoplasm Transplantation; Neoplasms, Experimental; Thymidine; Time Factors; Transplantation, Homologous; Tritium | 1972 |
Oral activity of 1-beta-D-arabinofuranosylcytosine in a transplantable hamster melanoma.
Topics: Administration, Oral; Animals; Cheek; Cricetinae; Cytarabine; Immunization, Passive; Injections, Intraperitoneal; Melanoma; Mouth Neoplasms; Neoplasm Transplantation; Time Factors; Transplantation, Homologous | 1971 |
A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878).
Topics: Adenocarcinoma; Blood Cells; Bone Marrow; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Cytarabine; Female; Hematopoiesis; Humans; Leiomyosarcoma; Leukocyte Count; Liver; Lung Neoplasms; Melanoma; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Sarcoma; Ureteral Neoplasms; Urethral Neoplasms | 1970 |